TIETOJA TÄSTÄ JAKSOSTA

Englanti
Yhdysvallat

TRANSKRIPTIO 🔗

HAE EDELLISIÄ EPISODEJA

Hae kanavan Beyond The Script vanhoja jaksoja.

MUITA jaksoja TÄSSÄ PODCASTISSA

EP2 - Robert Jappie, partner at Fieldfisher LLP and Tim Kirby, CEO at Releaf unpack the challenges and opportunities shaping the UK’s medical cannabis landscape, from the slow-moving regulatory environment to the urgent need for patient-focused innovation. Key topics include: - Why the UK's medical…
EP5 - Join COO of Releaf, Graham Woodward, and Dr Anne Katrin Schlag, Head of Research at Drug Science, as they explore how the UK can move from anecdotal patient stories to real-world evidence, and why this shift is vital for expanding safe, trusted access to cannabis-based medicines. Let's rethin…
EP3 - In this special edition episode, Releaf COO Graham Woodward sits down with cannabinoid pharmacologist Professor Saoirse O’Sullivan to explore whether our current approach to cannabis-based treatment is truly evidence-led or built on outdated myths. From the science behind THC and CBD to the …
EP1 - CEOs Tim Kirby of Releaf and James Duckenfield of Glass Pharm sat down to discuss the ever-evolving UK medical cannabis sector. In 2024, we joined forces with Glass Pharms in the UK's largest ever medical cannabis deal, providing Releaf patients with a consistent, high-quality supply of…
Vastuuvapautusilmoitus: Tälle sivulle upotettu podcast ja kuvitus ovat peräisin Releaf:ltä, joka on sen omistajan omaisuutta, eikä se ole sidoksissa Listen Notes, Inc:n tukemaan.